
CogniTech Labs Achieves 60+ WPM and Advanced Control with Breakthrough Non-Invasive BCI in Phase 2 Trials
CogniTech Labs Unveils Landmark Success in Non-Invasive BCI Clinical Trials PALO ALTO, CA – CogniTech Labs today announced the successful completion of its Phase 2 human clinical trials for the company’s innovative non-invasive high-bandwidth brain-computer interface (BCI) system. The trials, a significant milestone in the development of BCI technology, were conducted over a rigorous six-month…